62.2 F
New York
Friday, September 24, 2021

Why Enlivex [NASDAQ: ENLV] Shares Skyrocketing Today?

Must read

XPeng [NYSE: XPEV] Backed HT Aero Launch Flying Vehicle City Usage Scenarios

XPeng Inc. disclosed that HT Aero has launched future urban usage scenarios for its fifth-generation flying vehicle XPeng X2 (X2). It includes independent...

Metrospaces Choose Cryptobucks as Preferred Cryptocurrency Partner

Metrospaces disclosed that it has selected Cryptobucks as its preferred cryptocurrency partner. It has inked an agreement to consolidate Cryptobucks into all of its...

Novartis [NYSE: NVS] Announces Acquisition of Arctos Medical

Novartis AG disclosed that it has acquired Arctos Medical. This purchase decision will add a pre-clinical optogenetics-based AAV gene therapy program and Arctos’...

Mastercard [NYSE: MA] Announces Launch of Sustainability Innovation Lab

Mastercard Incorporated has introduced a new sustainability innovation lab. The firm disclosed that its new lab will lead the further development of the...

Shares of Enlivex Therapeutics Ltd. [NASDAQ: ENLV] skyrocketed 15.04% during the trading session of Monday. The strong performance of the firm has highlighted the positive sentiments of the investors after the firm disclosed that it has got ab green signal to commence a Phase 2b clinical trial for its cure of severe and critical COVID-19 sufferers with the acute respiratory distressed syndrome (ARDS).

The Phase IIb trial is anticipated to hire more than 152 acute or critical COVID-19 sufferers in clinical centers in Israel and certain European countries. Moreover, it is intended to evaluate the safety and efficacy of AllocetraTM when directed in addition to standard of care medication.

Enlivex Therapeutics Ltd. [NASDAQ: ENLV] shares were trading up 15.04% as the firm has gained +1.52 at the time of writing on Monday. Enlivex Therapeutics Ltd.’s share price went from a low point around $4.49 to briefly over $29.40 in the past 52 weeks, though shares have since pulled back to $12.17. ENLV’s market cap has remained high, reaching $193.94 million at the time of writing.

Furthermore, the scheduled Phase IIb clinical trial will have two primary endpoints. One is ventilation-free survival and another one is recovery for each of the two sub-populations of sufferers in the study. Additionally, the experiment will evaluate several secondary endpoints, including assessment of long-COVID-19 symptoms.

Moreover, Enlivex earlier described positive top-line results from Phase Ib and Phase II investigator-initiated clinical tests of AllocetraTM in COVID-19 sufferers in serious and critical conditions.

More articles

Latest article

ReneSola [NYSE: SOL] and Eiffel’s Joint Venture Buys Its First 200 MW Project Portfolio

ReneSola Ltd disclosed that European Solar Energy Development JV has finalized the purchase of its first batch of solar projects with a combined...

Square [NYSE: SQ] Launch its Early Access Program in Spain

Square, Inc. which has earned a reputation as a software, payments, and hardware solution firm for all types of businesses disclosed that it...

Ideanomics [NASDAQ: IDEX] Decides to Increase Stake in Energica

Ideanomics, Inc. disclosed that it has decided to ink an agreement with Energica Company. As per the agreement, the firm has decided to...

L3Harris’ [NYSE: LHX] Robot Chosen to Protect US Air Force Bases Around the Globe

L3Harris Technologies, Inc. disclosed that it has received a huge contract from US Air Force. The firm revealed that its robot will now...

Tower Semiconductor [NASDAQ: TSEM] Introduces Breakthrough LiDAR Technology

Tower Semiconductor Ltd. has introduced a breakthrough development of LiDAR IC technology created for sophisticated driver-assistance systems (ADAS) and ultimately self-driving cars. The...

KKR [NYSE: KKR] Decides to Divest Riata Corporate Park

KKR & Co. Inc. has disclosed that it has decided to divest the Riata Corporate Park. Riata Corporate Park is an eight-building, 688,100...

3D Systems [NYSE: DDD] Unveil VisiJet Wax Jewel Red

3D Systems Corporation has launched the VisiJet Wax Jewel Red. It will allow jewelry makers to design and create more sophisticated, lasting patterns....

Xerox [NYSE: XRX] Announces Transfer of Stock Exchange Listing to Nasdaq from NYSE

Xerox Holdings Corporation has made an important announcement regarding its listing on Stock Exchange. The firm has revealed that it has decided to...